M

Researcher Profile

Maoyong Fu

0000-0003-2645-9832

3

Publications

157

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article International Journal of Clinical Oncology Mar 28, 2026

Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer

Binwen Xu · Hanxiao Wang · Chengcheng Zhang · Tao Luo +5 more

10.1007/s10147-026-03018-x

Open Access Journal Article World Journal of Surgical Oncology Nov 01, 2024

Clinical outcomes of conversion surgery after induction immunochemotherapy for borderline resectable T4 esophageal squamous cell carcinoma

Chengcheng Zhang · Binwen Xu · Tao Luo · Yue Zhang +3 more

10.1186/s12957-024-03570-8 6 citations

Open Access Journal Article Nature Medicine Jul 02, 2024

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin · Liyan Xue · Anlin Hao · Xiaofeng Guo +40 more

10.1038/s41591-024-03064-w 151 citations

Publication Timeline

2026

1

2024

2

Frequent Co-Authors

Chengcheng Zhang